Cleared Traditional

K260733 - MRIA Radiation Therapy Information System (MRIA)

K260733 is an FDA 510(k) clearance for MRIA Radiation Therapy Information Syst..., manufactured by Manteia Technologies Co., Ltd.. The device is a Class 2 Radiology device with product code IYE cleared through the Traditional 510(k) pathway after a 173-day FDA review.

K260733 · Manteia Technologies Co., Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2026
Decision
173d
Days
Class 2
Risk

K260733 is an FDA 510(k) clearance for the MRIA Radiation Therapy Information System (MRIA). Classified as Accelerator, Linear, Medical (product code IYE), Class II - Special Controls.

Submitted by Manteia Technologies Co., Ltd. (Xiamen, CN). The FDA issued a Cleared decision on August 26, 2026 after a review of 173 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Manteia Technologies Co., Ltd. devices

FDA 510(k) Submission Details - K260733

510(k) Number K260733 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 06, 2026
Decision Date August 26, 2026
Days to Decision 173 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
66d slower than avg
Panel avg: 107d · This submission: 173d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

IYE Device Classification - Class 2, Special Controls

Product Code IYE Accelerator, Linear, Medical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IYE Accelerator, Linear, Medical

All 528
Devices cleared under the same product code (IYE) and FDA review panel - the closest regulatory comparables to K260733.
Halcyon, Ethos Radiotherapy System (5.0)
K261856 · Varian Medical Systems, Inc. · Aug 2026
ThinkQA 3
K252937 · Dosisoft SA · Jun 2026
LUNA 3D
K253004 · Lap GmbH Laser Applikationen · Jun 2026
AerFrame Patient Immobilization System (AFPIS)
K260792 · Stabilix, LLC · May 2026
VERIQA RT EPID 3D
K252258 · Ptw-Freiburg Physikalisch-Technische-Werkstaetten Dr. Pychla · Apr 2026
ClearCheck (RADCC V2.7)
K253962 · Radformation, Inc. · Apr 2026